Quest Diagnostics announced that Sam Samad, their Executive Vice President and CFO, will participate in a fireside chat at the 9th Annual Evercore Healthcare Conference on December 1, 2026. The event will be webcast live and available for replay until December 15, 2026, on the company's investor relations website. This appearance offers investors insight into the company's strategies and financial outlook. Quest Diagnostics is a major player in diagnostic services, serving half of U.S. physicians and hospitals annually.
Quest Diagnostics shares are currently trading at USD 258.45 on Pluang, showing a 1.10% increase as of Nov 10, 2026 00:51 WIB. The stock has a market cap of $28.21 billion and offers a dividend yield of 1.35%.
